Patents by Inventor Gijsbert Grotenbreg

Gijsbert Grotenbreg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
    Publication number: 20250025544
    Abstract: Disclosed herein are vectors that include antigen-encoding nucleic acid sequences and co-express immune modulators. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
    Type: Application
    Filed: January 4, 2024
    Publication date: January 23, 2025
    Inventors: Wade Blair, Karin Jooss, Leonid Gitlin, Ciaran Daniel Scallan, Amy Rachel Rappaport, Gijsbert Grotenbreg
  • VIRAL DELIVERY OF NEOANTIGENS
    Publication number: 20240067985
    Abstract: Disclosed herein are chimpanzee adenoviral vectors that include neoantigen-encoding nucleic acid sequences derived from a tumor of a subject. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
    Type: Application
    Filed: January 10, 2023
    Publication date: February 29, 2024
    Inventors: Wade Blair, Brendan Bulik-Sullivan, Jennifer Busby, Adnan Derti, Leonid Gitlin, Karin Jooss, Ciaran Daniel Scallan, Roman Yelensky, Gijsbert Grotenbreg
  • IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
    Publication number: 20210213122
    Abstract: Disclosed herein are vectors that include antigen-encoding nucleic acid sequences and co-express immune modulators. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
    Type: Application
    Filed: May 23, 2019
    Publication date: July 15, 2021
    Applicant: Gritstone Oncology, Inc.
    Inventors: Wade Blair, Karin Jooss, Leonid Gitlin, Ciaran Daniel Scallan, Amy Rachel Rappaport, Gijsbert Grotenbreg
  • VIRAL DELIVERY OF NEOANTIGENS
    Publication number: 20200010849
    Abstract: Disclosed herein are chimpanzee adenoviral vectors that include neoantigen-encoding nucleic acid sequences derived from a tumor of a subject. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
    Type: Application
    Filed: November 22, 2017
    Publication date: January 9, 2020
    Inventors: Wade Blair, Brendan Bulik-Sullivan, Jennifer Busby, Adnan Derti, Leonid Gitlin, Gijsbert Grotenbreg, Karin Jooss, Ciaran Daniel Scallan, Roman Yelensky